“Rollins is many things,” says the Washington Post, “diatribist, confessor, provocateur, humorist, even motivational speaker…his is an enthusiastic and engaging chatter.” Rollins has toured the world as a spoken word artist, as frontman for both Rollins Band and Black Flag and as a solitary traveler with insatiable curiosity, favoring road-less-traveled locales in places such as Nepal, Sri Lanka, Siberia, North Korea, South Sudan and Iran.
9:30 TRANSITIONING TO LEGAL USE – CANADA MOVES FORWARD
2018 will be a transformative year in Canadian and international cannabis policy. Canada will legalize recreational cannabis and provincial governments are busy implementing retail sales systems. A key component of this process will be transitioning the current, vibrant but mostly illicitly industry into the legal, regulated space. The next era will be marked by these transitions and this panel seeks to explore some of those implications.
The CSE – Canadian Securities Exchange will be providing insight into the process of going public and raising capital in the ever-evolving Cannabis sector. Anna Serin, Director of Listing Development for the CSE, will be moderating a panel discussion with industry professionals who will share their knowledge and experience. This panel will address many of the common questions asked during the process of going public, and will speak to the complex nature, jurisdictional issues and industry specific challenges facing today’s Canadian – and U.S. – Cannabis companies in the capital markets.
10:45 MERGERS AND ACQUISITIONS: INCREASING YOUR COMPANY’S VALUE, MARKET SHARE, AND RISK
While cannabis stocks – and hopes – continue to climb, Canadian companies are consolidating almost as fast as new licenses are approved. From takeovers (hostile and otherwise) to mergers, companies are increasing value, market share, and achieving almost full vertical integration. This panel shares their experience in this rapidly evolving space, and examines both the pitfalls and rewards.
11:15 HIGH STAKES – INTERNATIONAL CANNABIS INVESTMENTS AND OPPORTUNITIES
This session will present hard-hitting facts and advice for those considering investing or operating in the international cannabis markets. Investing in the “Green Rush” is extremely complex, and not for the faint of heart. Nic Easley, a globally recognized cannabis industry expert, multiple business owner, and venture fund manager will guide you through these emerging markets, helping you reduce risk while capturing upside opportunities to make impactful profitable companies. You’ll be better prepared to navigate these treacherous cannabis markets after attending this session.
The German medical cannabis market has shown great growth over the last year as the number of patients has increased exponentially, utilizing cannabis imported from Canada and the Netherlands. The industry in the EU powerhouse is poised to continue expanding as medical use goes more mainstream and the nation eventually licenses cultivation companies located in Germany. With insurers covering the cost of patients’ medicinal cannabis, Germany is leading the way in many respects and will only be more influential in the coming years.
The hour will be packed with cannabis entrepreneurs seeking a micro-licences under the new proposed regulations as they pitch their business plans to a panel of industry experts. Canopy Rivers is putting up to $1,000,000 of capital on the table for the most compelling pitches.
2:00 MEDIA & MARKETING: MAINSTREAMING CANNABIS & BUILDING CONSUMER TRUST
The days of counter culture content are slowly being supplanted with tried and true storytelling. Authentic stories and how they are marketed are key drivers of helping consumers discover cannabis brands that matter to them. Hear from industry leaders across media, marketing, content and cultivation to learn how they’re shaping elevated experiences for today’s mainstream consumer.
2:30 CANADIAN PHYSICIANS’ EXPERIENCE WITH MEDICAL CANNABIS
Our roundtable discussion with Canadian physicians currently prescribing cannabis to patients will delve into the multitude of issues facing patients and their doctors. Topics to be covered: How has the acceptance of medical cannabis by physicians and Canadian regulatory bodies changed over the years? Do patients have reasonable access to medicine or is the system broken? What benefits have doctors seen firsthand and what is the status of clinical trials? Will insurance coverage of medicinal cannabis be a game changer? What types of technology is used to help patients access cannabis? And more!
3:00 CANNABIS GENETICS: POTENTIAL PATENTS, TAILOR-MADE STRAINS, AND MORE IMPLICATIONS
It all starts with the plant! Despite legalization in various States and coming to Canada, no system has accurately taken into account the role of genetics. From possible patents, to the development of specific-effect strains, to the protection of biodiversity, to impacts of outdoor growing, particularly of THC-limited strains, pros share where we are at, and what’s at stake.
With ever-tightening regulations and oversight related to Cultivation, our panel of elite Industry scientists and growers will discuss topics ranging from regenerative farming and breeding, to organic pesticides and microbial screening methods as they relate to more stringent and evolving testing requirements.
Specialization is a major factor attracting capital and helping grow the Cannabis sector at hyper-speed. As businesses scale, focused models will be a necessity from both economic and regulatory perspectives, allowing companies to position and embed into the Industry value chain alongside other ‘specialists’. Our panel of Industry experts will discuss strategy in identifying synergies in prospective strategic partners and offer their insights related to making these significant decisions which can be a determining factor in the survival and ultimate success of your business.
Available to first 50 qualified applicants only. Click HERE to apply. PRØHBTD creates, builds and markets cannabis brands to global audiences. The company has helped more than 100 cannabis companies build their businesses through a variety of brand development and content programs. CEO Drake Sutton-Shearer will lead this exclusive opportunity to learn about cannabis brand building. Drake has spent the past 25 years helping some of the biggest brands in the world introduce and scale their products and services. In this fast paced and informational seminar you will learn how to develop a cannabis brand that will drive sales, create customer loyalty and work within the restrictive framework of Canadian packaging requirements.
VANCOUVER EARLY BIRD TICKETS! SAVE $200 USD WHEN BUYING BEFORE MIDNIGHT JUNE 23!